|
May 6
|
Eli Lilly signs $415m deal for Alchemab’s ALS therapy
|
|
May 6
|
Pharma M&A deal value surges by 101% QoQ in Q1 2025 despite US political turbulence
|
|
May 6
|
The Chinese market experienced significant growth in March – GlobalData
|
|
May 6
|
Emerging tech adoption slows amid global uncertainty
|
|
May 6
|
Temu confirms end of DTC parcels from China to US consumers
|
|
May 6
|
GLP-1 receptor agonists poised to redefine treatment paradigms beyond diabetes and obesity
|
|
May 6
|
Geopolitical conflict tops business concerns for first time in years
|
|
May 6
|
Bristol Myers Squibb announces $40bn US investment plan over five years
|
|
May 6
|
Study explores interplay between air pollution, genes, and Parkinson’s disease
|
|
May 6
|
Uranium crunch: the race to fuel the West’s nuclear energy revival
|
|
May 2
|
US light vehicle sales: Rush to buy vehicles pre-tariffs continues in April, but outlook uncertain – GlobalData
|
|
May 2
|
Q1 earnings pulse check: companies tentative on pharma-specific tariffs
|
|
May 2
|
Unearthing uranium: read the May issue of MINE today!
|
|
May 2
|
AstraZeneca’s triple-combo triumphs in two Phase III asthma trials
|
|
May 2
|
Global fashion industry expects 20% price hike on US tariffs
|
|
May 2
|
PTSD market expected to reach $5.5bn across the 7MM by 2034
|
|
May 1
|
Biogen’s Q1 revenue soars past estimates as rare disease pivot pays off
|
|
May 1
|
Lilly’s Q1 2025 revenue jumps 45%, but CVS shift boosts Novo’s Wegovy
|
|
May 1
|
FDA approves Edwards’ TAVR system for asymptomatic aortic stenosis patients
|
|
May 1
|
Auto Shanghai 2025: Huawei’s ‘Auto Wintel’ ecosystem – reshaping China’s smart vehicle industry
|